Angiopoietin-like protein 8/betatrophin as a new determinant of type 2 diabetes remission after bariatric surgery
- 1 June 2017
- journal article
- research article
- Published by Elsevier in Translational Research
- Vol. 184, 35-44.e4
Abstract
No abstract availableKeywords
Funding Information
- Spanish Ministry of Economy and Competitiveness
- European Regional Development
This publication has 37 references indexed in Scilit:
- Retraction Notice to: Betatrophin: A Hormone that Controls Pancreatic β Cell ProliferationCell, 2017
- The Rise and the Fall of Betatrophin/ANGPTL8 as an Inducer ofβ-Cell ProliferationJournal of Diabetes Research, 2016
- Betatrophin—Promises Fading and Lessons LearnedCell Metabolism, 2014
- ANGPTL8/Betatrophin Does Not Control Pancreatic Beta Cell ExpansionCell, 2014
- Elevated Mouse Hepatic Betatrophin Expression Does Not Increase Human β-Cell Replication in the Transplant SettingDiabetes, 2014
- Mice lacking ANGPTL8 (Betatrophin) manifest disrupted triglyceride metabolism without impaired glucose homeostasisProceedings of the National Academy of Sciences, 2013
- RETRACTED: Betatrophin: A Hormone that Controls Pancreatic β Cell ProliferationCell, 2013
- Emerging roles of Lipasin as a critical lipid regulatorBiochemical and Biophysical Research Communications, 2013
- Identification of RIFL, a novel adipocyte-enriched insulin target gene with a role in lipid metabolismAmerican Journal of Physiology-Endocrinology and Metabolism, 2012
- Identification of genes differentially expressed in human hepatocellular carcinoma by a modified suppression subtractive hybridization methodInternational Journal of Cancer, 2004